Welcome to PsychiatryAI.com: [PubMed] - Psychiatry AI Latest

A Double-blind, Randomized, Placebo-controlled plus Open Trial of Adjunctive Suvorexant for Treatment-resistant Insomnia in Patients with Bipolar Disorder

Evidence

CNS Spectr. 2024 May 24:1-26. doi: 10.1017/S1092852924000336. Online ahead of print.

NO ABSTRACT

PMID:38782461 | DOI:10.1017/S1092852924000336

Document this CPD Copy URL Button

Google

Google Keep

LinkedIn Share Share on Linkedin

Estimated reading time: 1 minute(s)

Latest: Psychiatryai.com #RAISR4D Evidence

Cool Evidence: Engaging Young People and Students in Real-World Evidence

Real-Time Evidence Search [Psychiatry]

AI Research

A Double-blind, Randomized, Placebo-controlled plus Open Trial of Adjunctive Suvorexant for Treatment-resistant Insomnia in Patients with Bipolar Disorder

Copy WordPress Title

🌐 90 Days

Evidence Blueprint

A Double-blind, Randomized, Placebo-controlled plus Open Trial of Adjunctive Suvorexant for Treatment-resistant Insomnia in Patients with Bipolar Disorder

QR Code

☊ AI-Driven Related Evidence Nodes

(recent articles with at least 5 words in title)

More Evidence

A Double-blind, Randomized, Placebo-controlled plus Open Trial of Adjunctive Suvorexant for Treatment-resistant Insomnia in Patients with Bipolar Disorder

🌐 365 Days

Floating Tab
close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI RAISR 4D System Psychiatry + Mental Health